Health · 1 views
Experimental treatment significantly slows progression of a fatal brain disease in women during clinical trial
Researchers at Tel Aviv University have presented new findings indicating that the experimental drug Davunetide may significantly slow th…
AI Summary
Researchers at Tel Aviv University have presented new findings indicating that the experimental drug Davunetide may significantly slow the progression of progressive supranuclear palsy (PSP) in women, who exhibited a markedly different response to treatment than men. These results reinforce the need for sex-specific medicine in neurodegenerative diseases.
Read full article on MedicalxpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedEnjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNowMore from Health
Continue reading recent Health coverage